This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Patrick Daugherty
Chief Scientific Officer at Serimmune


Patrick Daugherty is the Chief Scientific Officer of Serimmune. Daugherty received his B.S. in Chemical Engineering from The University of Minnesota in 1993, and his Ph.D. from the University of Texas at Austin in 1999.  He was a Research Fellow at the Fred Hutchinson Cancer Research Center in Seattle during 1999-2001, before joining the Chemical Engineering faculty at UCSB in 2001. At UCSB, Daugherty was promoted to Associate (2005) and full Professor (2008), and served on the faculty until 2015. He is the recipient of a National Sciences Foundation Career Award (2005), Camille Dreyfus Teacher Scholar Award (2006), and the Genentech Young Investigator Award from the ACS Division of Biochemical Technology (2007). Daugherty co-founded CytomX Therapeutics, Inc. (2008) – Nasdaq:CTMX and Serimmune Inc. (2014). Daugherty was elected to the American Institute of Medical and Biological Engineering (AIMBE) in 2011, honoring the top 2% of bioengineers.   Daugherty’s research and work is focused on the development of methods to map serological antibody repertoires to their antigens.

Agenda Sessions

  • Antigen Targets of Antibody Repertoires in Health and Disease Via Serum Epitope Repertoire Analysis